Women's Health

The overall survival hazard ratio numerically favored niraparib in the germline BRCA mutation cohort and favored placebo in the non-germline BRCA mutation cohort in patients with platinum-sensitive recurrent ovarian cancer.

Women who are pregnant should continue or start treatment with alternative or preferred antiretroviral therapies for viral suppression, investigators suggest.

Pharmacists respond to questions about birth control.

Legal expert breaks down the history of power between federal v. state law and why Dobbs v. Jackson has caused such a stir for the pharmaceutical community.

Improvements in progression-free survival were seen in patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.

Dobbs v. Jackson muddied the waters for pharmacists in strict abortion states, who must make decisions despite misaligned state and federal laws.

For the management of ovarian cancer, it has been observed in both cellular and animal models that curcumin suppresses cell proliferation and promotes apoptosis.

Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.

Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.

Hydroxyprogesterone caproate injection was the only drug approved to help prevent preterm birth, but a confirmatory trial showed no benefit.

Food insecurity was also higher among Hispanic and Black women compared with White women, with 1 in 4 Black women and 1 in 3 Hispanic women reporting food insecurity.

The efficacy of 2 doses against Omicron infection was highest when the second vaccine dose was given in the third trimester of pregnancy compared with the first or second trimesters.

Clinical guidelines suggest screening for cardiovascular risk factors post-partum in women, however, these recommendations are not closely followed, a new study suggests.

Metformin may accelerate paclitaxel’s actions on cell replication in endometrial cancer.

Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.

Arrhythmia was found to be the most common cardiovascular complication of COVID-19.

Trial meets its primary endpoint of progression-free survival regardless of mismatch repair status in patients with stage 3 or 4 or recurrent endometrial carcinoma.

By binding to and inhibiting RANKL, denosumab decreases the production and activity of osteoclasts, resulting in reduced bone loss.

Earlier this week, the FDA Oncologic Drugs Advisory Committee also voted 8 to 5 in support of data for dostarlimab-gxly in rectal cancer.

Multiple adverse outcomes were associated with an even higher risk of heart disease.

JNJ-80202135 (nipocalimab) treats hemolytic disease of the fetus and newborn caused by maternal red blood cells.

Vitamin D supplementation is a vital and inexpensive way to prevent and treat deficiency; however, its use in preventing and treating other conditions is less clear.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

Patients who received the interventions reported improved anxiety and pain levels.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Although the FDA has now allowed retail pharmacies to dispense mifepristone, a drug used for medicated abortions, questions still remain about the requirements for pharmacies and the availability of the drug.

Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.

Pharmacists are ideally positioned within communities to identify patients struggling with perinatal depression.

Following the positive phase 3 results, GSK anticipates regulatory submissions in the first half of 2023.